プロモーションスケジュール Chimeric Therapeutics Limited
詳細なスケジュール
簡易グラフ
会社について Chimeric Therapeutics Limited
Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies in oncology in Australia. The company develops CHM 0201 (core NK platform) that is in phase I clinical trial for treating solid tumors and hematological malignancies; and CHM 1101 (CLTX CAR T), which is in phase I clinical trial for treating patients with MMP2+ recurrent or progressive glioblastoma. さらに詳しく| Industry | Biotechnology |
|---|---|
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.chimerictherapeutics.com |
| Цена ао | 0.001 |
| 1日あたりの価格変動: | 0% (0.001) |
|---|---|
| 週ごとの価格変動: | 0% (0.001) |
| 月ごとの料金変更: | 0% (0.001) |
| 3ヶ月間の価格変動: | 0% (0.001) |
| 半年間の価格変動: | 0% (0.001) |
| 年間の価格変動: | -96.67% (0.03) |
| 年初からの価格変動: | 0% (0.001) |
|
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
|||||||||||||||||||||||||||||||||||||
| スーパーバイザー | 役職 | 支払い | 生年 |
|---|---|---|---|
| Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD | Founder & Executive Chairman | 1956 (69 年) | |
| Mr. Jason B. Litten M.D. | Chief Medical Officer | 1974 (51 年) | |
| Mr. Phillip Allen Hains BBus(Acc), C.A., M.B.A. | CFO, Joint Company Secretary & Director | 1959 (66 年) | |
| Dr. Rebecca McQualter | Chief Operating Officer | ||
| Mr. Kelly R. Thornburg | VP & Head of Quality | 1963 (62 年) | |
| Mr. Nathan Jong C.A. | Company Secretary |
住所: Australia, Carlton, 62 Lygon Street - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.chimerictherapeutics.com
Webサイト: https://www.chimerictherapeutics.com
